Poor medication timing, incorrect doses, medication disorganization, and under- or over-medication are some of the medication adherence issues that can occur in patients with MS and cognitive symptoms.
The association suggests that caffeine consumption may play a protective role against multiple sclerosis-related disability.
Intakes of fats and types of fatty acids may affect disability severity in multiple sclerosis and neuromyelitis optica spectrum disorder.
Vitamin D deficiency is a risk factor for multiple sclerosis.
Data obtained from the iConquerMS network highlight areas of quality of life that affect people with relapsing and progressive forms of MS and provide substantial basis for future research.
Patients with multiple sclerosis who were motivated to remain adherent to treatment experienced overall better outcomes, including low relapse rates.
Barriers to using screening tools included lack of time and lack of insurance compensation.
Researchers aimed to determine the proportion of patients with early relapsing-remitting multiple sclerosis treated with natalizumab who achieve no evidence of disease activity at year 2.
Authors describe 2 case reports of MS in the pediatric population after administration of HPV vaccination.
Researchers examined patients’ disease course and the number of clinical attacks to determine the safety and efficacy of intravenous cladribine.
